Actually I said quite the opposite. The investment community easily saw the value of the PR and the enormous future potential of breaking into the Canadian market, not to mention that the PR only strengthens CytoDyn's application for the mTNBC BTD. This 6-15% increase today will be a blip on the radar compared to what it's going to look like if we get FDA approval on the BTD. Everyone knows that, and it's driving the shorts nuts that NP gets FULL CREDIT for moving the mTNBC BTD forward! NP has accomplished more this month than Tony C. did during his entire tenure at CYDY.
In my opinion, what we see exemplified in this post is the difference between a “trading” mentality and an “investing” mentality. Those with a trading mentality will look at the Canada news and say “there is no large scale revenue immediately associated with it, so there is no value to it.” Those with an investing mentality will look at the news and think about all the positive dominoes that are set to fall downstream due to the practical effects of what is actually occurring in Canada.